Hearing Study: Sensitivity to Features of Speech Sounds
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03666676 |
|
Recruitment Status :
Recruiting
First Posted : September 12, 2018
Last Update Posted : November 17, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Hearing Loss, Sensorineural | Other: Signal processing to improve intelligibility | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 200 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Basic Science |
| Official Title: | Auditory Processing of Complex Sounds - Sensitivity to Chirps |
| Actual Study Start Date : | June 9, 2020 |
| Estimated Primary Completion Date : | November 30, 2023 |
| Estimated Study Completion Date : | November 30, 2023 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Normal Hearing
Signal processing to improve intelligibility
|
Other: Signal processing to improve intelligibility
Signal processing will be used to manipulate frequency and amplitude fluctuations in complex sounds. |
|
Active Comparator: Mild hearing loss
Signal processing to improve intelligibility
|
Other: Signal processing to improve intelligibility
Signal processing will be used to manipulate frequency and amplitude fluctuations in complex sounds. |
|
Active Comparator: Moderate hearing loss
Signal processing to improve intelligibility
|
Other: Signal processing to improve intelligibility
Signal processing will be used to manipulate frequency and amplitude fluctuations in complex sounds. |
- Discrimination thresholds for formant-freq difference limens [ Time Frame: 5 years ]Measures of discrimination thresholds (in units of "% of Formant Frequency" at the discrimination threshold) for different formant bandwidths and for different alignments of formants and harmonics.
- % of correct synthetic vowels [ Time Frame: 5 years ]% correct answers
- % of correct synthetic syllables [ Time Frame: 5 years ]% correct answers
- % of correct words [ Time Frame: 5 years ]% correct answers using SPiN test
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Normal hearing, mild or moderate symmetric sensorineural hearing loss.
Exclusion Criteria:
- Asymmetric hearing thresholds (more than 15 decibels (dB) threshold difference between the two ears at any frequency up to 4 kHz).
- Severe hearing loss (greater than 60 dB hearing thresholds at any frequency up to 4 kHz).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03666676
| Contact: Laurel H Carney | 5852763948 | laurel.carney@rochester.edu |
| United States, New York | |
| University of Rochester | Recruiting |
| Rochester, New York, United States, 14642 | |
| Contact: Laurel Carney 585-276-3948 laurel.carney@rochester.edu | |
| Responsible Party: | Laurel Carney, Professor, University of Rochester |
| ClinicalTrials.gov Identifier: | NCT03666676 |
| Other Study ID Numbers: |
73346 R01DC001641 ( U.S. NIH Grant/Contract ) |
| First Posted: | September 12, 2018 Key Record Dates |
| Last Update Posted: | November 17, 2021 |
| Last Verified: | November 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Hearing Loss Hearing Loss, Sensorineural Hearing Disorders Ear Diseases |
Otorhinolaryngologic Diseases Sensation Disorders Neurologic Manifestations Nervous System Diseases |

